Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Actelion
Actelion
Idorsia drug fails to quell binge eating in midphase trial, driving biotech to abandon the indication
Fierce Biotech
Tue, 05/10/22 - 10:39 am
Idorsia
clinical trials
ACT-539313
binge eating disorder
Actelion
Top 10 pharma settlements since 2018
Fierce Pharma
Tue, 11/19/19 - 10:27 am
settlements
Reckitt Benckiser
JNJ
Bayer
Allergan
Actelion
Purdue Pharma
Teva Pharmaceutical
Endo
Teikoku
Insys
Pfizer
GSK
Astellas
Amgen
Actelion inks $360M deal to resolve DOJ kickbacks probe
Fierce Pharma
Thu, 12/6/18 - 06:54 pm
JNJ
DOJ
PAH
Actelion
kickbacks
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
Yahoo/Reuters
Mon, 06/18/18 - 09:47 am
Indorsia
Actelion
JNJ
insomnia
FDA calls out 39 drug companies for allegedly blocking access to generics
Stat
Thu, 05/17/18 - 10:15 am
JNJ
Actelion
Celgene
Gilead
Novartis
Pfizer
Valeant Pharmaceuticals
generics
FDA
J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout
Endpoints
Tue, 04/17/18 - 11:08 am
JNJ
Actelion
antibiotics
C. difficile
cadazolid
Biotech sector ensures highest premium among M&A transactions
GoinPharma
Tue, 01/2/18 - 11:05 am
biotech
M&A
Kite Pharma
Gilead Sciences
JNJ
Actelion
J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
Endpoints
Mon, 12/4/17 - 11:43 am
JNJ
hypertension
Idorsia
Actelion
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
Mon, 08/14/17 - 10:03 am
biotech
M&A
JNJ
Actelion
Takeda
Ariad Pharmaceuticals
Gilead Sciences
Pfizer
Amgen
Johnson & Johnson closes $30B Actelion buyout
Drug Delivery Business News
Fri, 06/16/17 - 10:16 am
JNJ
Actelion
M&A
Johnson & Johnson wins last regulatory nod needed for Actelion acquisition
Drug Delivery Business News
Sat, 06/10/17 - 12:14 pm
JNJ
Actelion
M&A
EU
Europe
Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another
Fierce Biotech
Thu, 06/8/17 - 09:38 am
JNJ
Actelion
clinical trials
M&A
antibiotics
cadazolid
Minerva shares jump as J&J hands over $30M, revises insomnia drug pact; Iroko lays off 122
Endpoints
Sat, 06/3/17 - 09:17 am
Minerva Neurosciences
MIN-202
JNJ
Actelion
insomnia
Iroko Pharmaceuticals
Johnson & Johnson: Help Me Actelion, You're My Only Hope
Barron's
Tue, 04/18/17 - 09:01 pm
JNJ
Actelion
M&A
earnings
About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet
Fierce Pharma
Mon, 04/10/17 - 10:19 am
M&A
Stada
Shire
Baxalta
JNJ
Actelion
Mylan Labs
Pfizer
Takeda
Ariad Pharmaceuticals
Medivation
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
Actelion shareholders OK R&D spinout
Drug Delivery Business News
Wed, 04/5/17 - 12:04 pm
Actelion
R&D
spinoffs
JNJ
JNJ Declares Success of Actelion Tender, Sees Closing in Second Quarter
TheStreet.com
Fri, 03/31/17 - 10:08 am
JNJ
Actelion
M&A
4 Reasons Johnson & Johnson Surged 8% in February
Motley Fool
Thu, 03/2/17 - 03:46 pm
JNJ
Darzalex
Actelion
Donald Trump
What's wrong with Sanofi's dealmaking approach? To hear Actelion tell it, plenty
Fierce Pharma
Fri, 02/17/17 - 10:01 am
Sanofi
Actelion
M&A
Pages
1
2
3
4
5
6
7
8
next ›
last »